APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sunitinib Generics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sunitinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025187 pages

Choose your research edition.

Industry ResearchSunitinib Generics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sunitinib Generics Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Sunitinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sunitinib Generics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sunitinib Generics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sunitinib Generics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sunitinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sunitinib Generics include Aprazer Healthcare, Taj Pharma, Teva, Zydus, Hansoh Pharma, Hunan Kelun Pharmaceutical, Qilu Pharmaceutical, CSPC Pharmaceutical and Chia Tai Tianqing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sunitinib Generics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sunitinib Generics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sunitinib Generics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sunitinib Generics market size, projected growth trends, production technologies, key applications, and end-use industries.

Sunitinib Generics Segment by Company

Aprazer Healthcare

Taj Pharma

Teva

Zydus

Hansoh Pharma

Hunan Kelun Pharmaceutical

Qilu Pharmaceutical

CSPC Pharmaceutical

Chia Tai Tianqing

Sunitinib Generics Segment by Type

50mg per Unit

37.5mg per Unit

20mg per Unit

12.5mg per Unit

Sunitinib Generics Segment by Application

Pancreatic Neuroendocrine Tumors

Gastrointestinal Stromal Tumors

Renal cell Carcinoma

Other

Sunitinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sunitinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sunitinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sunitinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sunitinib Generics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sunitinib Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sunitinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sunitinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sunitinib Generics Industry Trends Table 2. Sunitinib Generics Industry Drivers Table 3. Sunitinib Generics Industry Opportunities and Challenges Table 4. Sunitinib Generics Industry Restraints Table 5. Global Sunitinib Generics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sunitinib Generics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sunitinib Generics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Sunitinib Generics Sales Market Share by Manufacturers Table 9. Global Sunitinib Generics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sunitinib Generics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sunitinib Generics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sunitinib Generics Manufacturers, Product Type & Application Table 13. Global Sunitinib Generics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sunitinib Generics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg per Unit Table 17. Major Manufacturers of 37.5mg per Unit Table 18. Major Manufacturers of 20mg per Unit Table 19. Major Manufacturers of 12.5mg per Unit Table 20. Global Sunitinib Generics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Sunitinib Generics Sales by Type (2021-2026) & (K Units) Table 22. Global Sunitinib Generics Sales by Type (2027-2032) & (K Units) Table 23. Global Sunitinib Generics Sales Market Share by Type (2021-2026) Table 24. Global Sunitinib Generics Sales Market Share by Type (2027-2032) Table 25. Global Sunitinib Generics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Sunitinib Generics Revenue by Type (2021-2026) & (K Units) Table 27. Global Sunitinib Generics Revenue by Type (2027-2032) & (K Units) Table 28. Global Sunitinib Generics Revenue Market Share by Type (2021-2026) Table 29. Global Sunitinib Generics Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pancreatic Neuroendocrine Tumors Table 31. Major Manufacturers of Gastrointestinal Stromal Tumors Table 32. Major Manufacturers of Renal cell Carcinoma Table 33. Major Manufacturers of Other Table 34. Global Sunitinib Generics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Sunitinib Generics Sales by Application (2021-2026) & (K Units) Table 36. Global Sunitinib Generics Sales by Application (2027-2032) & (K Units) Table 37. Global Sunitinib Generics Sales Market Share by Application (2021-2026) Table 38. Global Sunitinib Generics Sales Market Share by Application (2027-2032) Table 39. Global Sunitinib Generics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Sunitinib Generics Revenue by Application (2021-2026) & (K Units) Table 41. Global Sunitinib Generics Revenue by Application (2027-2032) & (K Units) Table 42. Global Sunitinib Generics Revenue Market Share by Application (2021-2026) Table 43. Global Sunitinib Generics Revenue Market Share by Application (2027-2032) Table 44. Global Sunitinib Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Sunitinib Generics Sales by Region (2021-2026) & (K Units) Table 46. Global Sunitinib Generics Sales Market Share by Region (2021-2026) Table 47. Global Sunitinib Generics Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Sunitinib Generics Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 51. North America Sunitinib Generics Sales by Country (2027-2032) & (K Units) Table 52. Europe Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 54. Europe Sunitinib Generics Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Sunitinib Generics Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Sunitinib Generics Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Sunitinib Generics Sales by Country (2027-2032) & (K Units) Table 61. Global Sunitinib Generics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Sunitinib Generics Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Sunitinib Generics Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Sunitinib Generics Revenue Market Share by Region (2021-2026) Table 65. Global Sunitinib Generics Revenue Market Share by Region (2027-2032) Table 66. Aprazer Healthcare Company Information Table 67. Aprazer Healthcare Business Overview Table 68. Aprazer Healthcare Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Aprazer Healthcare Sunitinib Generics Product Portfolio Table 70. Aprazer Healthcare Recent Development Table 71. Taj Pharma Company Information Table 72. Taj Pharma Business Overview Table 73. Taj Pharma Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Taj Pharma Sunitinib Generics Product Portfolio Table 75. Taj Pharma Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Teva Sunitinib Generics Product Portfolio Table 80. Teva Recent Development Table 81. Zydus Company Information Table 82. Zydus Business Overview Table 83. Zydus Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Zydus Sunitinib Generics Product Portfolio Table 85. Zydus Recent Development Table 86. Hansoh Pharma Company Information Table 87. Hansoh Pharma Business Overview Table 88. Hansoh Pharma Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Hansoh Pharma Sunitinib Generics Product Portfolio Table 90. Hansoh Pharma Recent Development Table 91. Hunan Kelun Pharmaceutical Company Information Table 92. Hunan Kelun Pharmaceutical Business Overview Table 93. Hunan Kelun Pharmaceutical Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Hunan Kelun Pharmaceutical Sunitinib Generics Product Portfolio Table 95. Hunan Kelun Pharmaceutical Recent Development Table 96. Qilu Pharmaceutical Company Information Table 97. Qilu Pharmaceutical Business Overview Table 98. Qilu Pharmaceutical Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Qilu Pharmaceutical Sunitinib Generics Product Portfolio Table 100. Qilu Pharmaceutical Recent Development Table 101. CSPC Pharmaceutical Company Information Table 102. CSPC Pharmaceutical Business Overview Table 103. CSPC Pharmaceutical Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. CSPC Pharmaceutical Sunitinib Generics Product Portfolio Table 105. CSPC Pharmaceutical Recent Development Table 106. Chia Tai Tianqing Company Information Table 107. Chia Tai Tianqing Business Overview Table 108. Chia Tai Tianqing Sunitinib Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Chia Tai Tianqing Sunitinib Generics Product Portfolio Table 110. Chia Tai Tianqing Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Sunitinib Generics Distributors List Table 114. Sunitinib Generics Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Sunitinib Generics Product Image Figure 2. Global Sunitinib Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sunitinib Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Sunitinib Generics Sales (2021-2032) & (K Units) Figure 5. Global Sunitinib Generics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sunitinib Generics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg per Unit Image Figure 9. 37.5mg per Unit Image Figure 10. 20mg per Unit Image Figure 11. 12.5mg per Unit Image Figure 12. Global Sunitinib Generics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Sunitinib Generics Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Sunitinib Generics Sales Market Share by Type (2021-2032) Figure 15. Global Sunitinib Generics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Sunitinib Generics Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Sunitinib Generics Revenue Market Share by Type (2021-2032) Figure 18. Pancreatic Neuroendocrine Tumors Image Figure 19. Gastrointestinal Stromal Tumors Image Figure 20. Renal cell Carcinoma Image Figure 21. Other Image Figure 22. Global Sunitinib Generics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Sunitinib Generics Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Sunitinib Generics Sales Market Share by Application (2021-2032) Figure 25. Global Sunitinib Generics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Sunitinib Generics Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Sunitinib Generics Revenue Market Share by Application (2021-2032) Figure 28. North America Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Sunitinib Generics Sales Market Share by Country (2021-2032) Figure 30. U.S. Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Sunitinib Generics Sales Market Share by Country (2021-2032) Figure 35. Germany Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Sunitinib Generics Sales Market Share by Country (2021-2032) Figure 42. China Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Sunitinib Generics Sales Market Share by Country (2021-2032) Figure 50. Brazil Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Sunitinib Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Sunitinib Generics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Sunitinib Generics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Sunitinib Generics Revenue (2021-2032) & (US$ Million) Figure 61. North America Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Sunitinib Generics Revenue (2021-2032) & (US$ Million) Figure 63. Europe Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Sunitinib Generics Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Sunitinib Generics Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Sunitinib Generics Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Sunitinib Generics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg per Unit
  • 37.5mg per Unit
  • 20mg per Unit
  • 12.5mg per Unit
Applications
  • Pancreatic Neuroendocrine Tumors
  • Gastrointestinal Stromal Tumors
  • Renal cell Carcinoma
  • Other
Companies covered
  • Aprazer Healthcare
  • Taj Pharma
  • Teva
  • Zydus
  • Hansoh Pharma
  • Hunan Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • CSPC Pharmaceutical
  • Chia Tai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sunitinib Generics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sunitinib Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sunitinib Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sunitinib Generics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sunitinib Generics Market Dynamics
  1. 2.1 Sunitinib Generics Industry Trends
  2. 2.2 Sunitinib Generics Industry Drivers
  3. 2.3 Sunitinib Generics Industry Opportunities and Challenges
  4. 2.4 Sunitinib Generics Industry Restraints
3 Sunitinib Generics Market by Manufacturers
  1. 3.1 Global Sunitinib Generics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sunitinib Generics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sunitinib Generics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sunitinib Generics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sunitinib Generics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sunitinib Generics Manufacturers, Product Type & Application
  7. 3.7 Global Sunitinib Generics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sunitinib Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sunitinib Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sunitinib Generics Tier 1, Tier 2, and Tier 3
4 Sunitinib Generics Market by Type
  1. 4.1 Sunitinib Generics Type Introduction
  2. 4.1.1 50mg per Unit
  3. 4.1.2 37.5mg per Unit
  4. 4.1.3 20mg per Unit
  5. 4.1.4 12.5mg per Unit
  6. 4.2 Global Sunitinib Generics Sales by Type
  7. 4.2.1 Global Sunitinib Generics Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sunitinib Generics Sales by Type (2021-2032)
  9. 4.2.3 Global Sunitinib Generics Sales Market Share by Type (2021-2032)
  10. 4.3 Global Sunitinib Generics Revenue by Type
  11. 4.3.1 Global Sunitinib Generics Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sunitinib Generics Revenue by Type (2021-2032)
  13. 4.3.3 Global Sunitinib Generics Revenue Market Share by Type (2021-2032)
5 Sunitinib Generics Market by Application
  1. 5.1 Sunitinib Generics Application Introduction
  2. 5.1.1 Pancreatic Neuroendocrine Tumors
  3. 5.1.2 Gastrointestinal Stromal Tumors
  4. 5.1.3 Renal cell Carcinoma
  5. 5.1.4 Other
  6. 5.2 Global Sunitinib Generics Sales by Application
  7. 5.2.1 Global Sunitinib Generics Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Sunitinib Generics Sales by Application (2021-2032)
  9. 5.2.3 Global Sunitinib Generics Sales Market Share by Application (2021-2032)
  10. 5.3 Global Sunitinib Generics Revenue by Application
  11. 5.3.1 Global Sunitinib Generics Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Sunitinib Generics Revenue by Application (2021-2032)
  13. 5.3.3 Global Sunitinib Generics Revenue Market Share by Application (2021-2032)
6 Global Sunitinib Generics Sales by Region
  1. 6.1 Global Sunitinib Generics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sunitinib Generics Sales by Region (2021-2032)
  3. 6.2.1 Global Sunitinib Generics Sales by Region (2021-2026)
  4. 6.2.2 Global Sunitinib Generics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sunitinib Generics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sunitinib Generics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sunitinib Generics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sunitinib Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sunitinib Generics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sunitinib Generics Revenue by Region
  1. 7.1 Global Sunitinib Generics Revenue by Region
  2. 7.1.1 Global Sunitinib Generics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sunitinib Generics Revenue by Region (2021-2026)
  4. 7.1.3 Global Sunitinib Generics Revenue by Region (2027-2032)
  5. 7.1.4 Global Sunitinib Generics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sunitinib Generics Revenue (2021-2032)
  8. 7.2.2 North America Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sunitinib Generics Revenue (2021-2032)
  11. 7.3.2 Europe Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sunitinib Generics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sunitinib Generics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sunitinib Generics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aprazer Healthcare
  2. 8.1.1 Aprazer Healthcare Company Information
  3. 8.1.2 Aprazer Healthcare Business Overview
  4. 8.1.3 Aprazer Healthcare Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aprazer Healthcare Sunitinib Generics Product Portfolio
  6. 8.1.5 Aprazer Healthcare Recent Developments
  7. 8.2 Taj Pharma
  8. 8.2.1 Taj Pharma Company Information
  9. 8.2.2 Taj Pharma Business Overview
  10. 8.2.3 Taj Pharma Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Taj Pharma Sunitinib Generics Product Portfolio
  12. 8.2.5 Taj Pharma Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Sunitinib Generics Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Zydus
  20. 8.4.1 Zydus Company Information
  21. 8.4.2 Zydus Business Overview
  22. 8.4.3 Zydus Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Sunitinib Generics Product Portfolio
  24. 8.4.5 Zydus Recent Developments
  25. 8.5 Hansoh Pharma
  26. 8.5.1 Hansoh Pharma Company Information
  27. 8.5.2 Hansoh Pharma Business Overview
  28. 8.5.3 Hansoh Pharma Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hansoh Pharma Sunitinib Generics Product Portfolio
  30. 8.5.5 Hansoh Pharma Recent Developments
  31. 8.6 Hunan Kelun Pharmaceutical
  32. 8.6.1 Hunan Kelun Pharmaceutical Company Information
  33. 8.6.2 Hunan Kelun Pharmaceutical Business Overview
  34. 8.6.3 Hunan Kelun Pharmaceutical Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hunan Kelun Pharmaceutical Sunitinib Generics Product Portfolio
  36. 8.6.5 Hunan Kelun Pharmaceutical Recent Developments
  37. 8.7 Qilu Pharmaceutical
  38. 8.7.1 Qilu Pharmaceutical Company Information
  39. 8.7.2 Qilu Pharmaceutical Business Overview
  40. 8.7.3 Qilu Pharmaceutical Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Qilu Pharmaceutical Sunitinib Generics Product Portfolio
  42. 8.7.5 Qilu Pharmaceutical Recent Developments
  43. 8.8 CSPC Pharmaceutical
  44. 8.8.1 CSPC Pharmaceutical Company Information
  45. 8.8.2 CSPC Pharmaceutical Business Overview
  46. 8.8.3 CSPC Pharmaceutical Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CSPC Pharmaceutical Sunitinib Generics Product Portfolio
  48. 8.8.5 CSPC Pharmaceutical Recent Developments
  49. 8.9 Chia Tai Tianqing
  50. 8.9.1 Chia Tai Tianqing Company Information
  51. 8.9.2 Chia Tai Tianqing Business Overview
  52. 8.9.3 Chia Tai Tianqing Sunitinib Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chia Tai Tianqing Sunitinib Generics Product Portfolio
  54. 8.9.5 Chia Tai Tianqing Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sunitinib Generics Value Chain Analysis
  2. 9.1.1 Sunitinib Generics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sunitinib Generics Production Mode & Process
  6. 9.2 Sunitinib Generics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sunitinib Generics Distributors
  9. 9.2.3 Sunitinib Generics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst